Igor N. Kuznetsov

12 Kutuzovsky Av
Moscow, MOW 121248, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Multi-Omics Profiling of oxylipins and gene expression in pediatric sarcomas identifies metastatic signatures and prognostic models.

Multi-Omics Profiling of oxylipins and gene expression in pediatric sarcomas identifies metastatic signatures and prognostic models.

Journal: Free radical biology & medicine

Published: March 06, 2026

Predicting renal-cell carcinoma recurrence after partial nephrectomy: a CT-radiomics approach.

Predicting renal-cell carcinoma recurrence after partial nephrectomy: a CT-radiomics approach.

Journal: International urology and nephrology

Published: October 22, 2025

Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications.

Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications.

Journal: Biomedicines

Published: December 30, 2024

Clinical and prognostic significance of the soluble form of the VISTA immunity control point in patients with primary bone tumors.

Clinical and prognostic significance of the soluble form of the VISTA immunity control point in patients with primary bone tumors.

Journal: Klinicheskaia laboratornaia diagnostika

Published: September 20, 2021

A facile and sensitive HPLC-MS/MS method for quantification of 3,3'-diindolylmethane in plasma samples.

A facile and sensitive HPLC-MS/MS method for quantification of 3,3'-diindolylmethane in plasma samples.

Journal: Biomedical chromatography : BMC

Published: June 08, 2021

Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.

Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.

Journal: Klinicheskaia laboratornaia diagnostika

Published: December 10, 2020

Morphometric Parameters of the Lung Tissue in Isolated Musculoskeletal Injuries under Conditions of Moderate Hyperhomocysteinemia.

Morphometric Parameters of the Lung Tissue in Isolated Musculoskeletal Injuries under Conditions of Moderate Hyperhomocysteinemia.

Journal: Bulletin of experimental biology and medicine

Published: January 23, 2020

An Experimental Study of the Effect of Diindolylmethane on Alveolocyte and Hepatocyte Adhesion Strength in Mice.

An Experimental Study of the Effect of Diindolylmethane on Alveolocyte and Hepatocyte Adhesion Strength in Mice.

Journal: Bulletin of experimental biology and medicine

Published: April 23, 2019

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention.

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention.

Journal: The EPMA journal

Published: October 09, 2015

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

Journal: The EPMA journal

Published: September 09, 2015

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

Journal: The EPMA journal

Published: August 08, 2014

Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer.

Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer.

Journal: Experimental oncology

Published: July 02, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026